Print this page

KEEPS
Kronos Early Estrogen Prevention Study
Ongoing trial
Author(s)
Harman SM, Brinton EA, Cedars M, Lobo R, Manson JE, Merriam GR, Miller VM, Naftolin F, Santoro N
Title(s)
KEEPS: The Kronos Early Estrogen Prevention Study
Reference(s)
Climacteric 2005;8:312
Disease
Cardiovascular disease
Purpose
To determine the effects of early initiation of hormone therapy on the prevention of cardiovascular disease in postmenopausal women
Study design
Randomised, double-blind, placebo-controlled
Follow-up
Aim 5 years
Patients
Aim 720 women, aged 42−58 years, within 36 months of their final menstrual period
Treatment regimen
Conjugated equine oestrogens, 0.45 mg/day, plus progesterone, 200 mg/day for 12 days each month, or transdermal oestradiol, 50 µg/week, plus progesterone, or placebo
Results
Not yet available
What's What

Back